CGEN
Price
$1.64
Change
-$0.07 (-4.09%)
Updated
Nov 4 closing price
7 days until earnings call
CYTK
Price
$51.48
Change
-$0.34 (-0.66%)
Updated
Nov 4 closing price
One day until earnings call
Ad is loading...

CGEN vs CYTK

Header iconCGEN vs CYTK Comparison
Open Charts CGEN vs CYTKBanner chart's image
Compugen
Price$1.64
Change-$0.07 (-4.09%)
Volume$153.05K
CapitalizationN/A
Cytokinetics
Price$51.48
Change-$0.34 (-0.66%)
Volume$718.73K
CapitalizationN/A
View a ticker or compare two or three
CGEN vs CYTK Comparison Chart
Loading...
CGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CGEN vs. CYTK commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEN is a StrongBuy and CYTK is a Hold.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (CGEN: $1.64 vs. CYTK: $51.48)
Brand notoriety: CGEN and CYTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEN: 74% vs. CYTK: 64%
Market capitalization -- CGEN: $147.4M vs. CYTK: $6.06B
CGEN [@Biotechnology] is valued at $147.4M. CYTK’s [@Biotechnology] market capitalization is $6.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEN’s FA Score shows that 0 FA rating(s) are green whileCYTK’s FA Score has 1 green FA rating(s).

  • CGEN’s FA Score: 0 green, 5 red.
  • CYTK’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than CGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEN’s TA Score shows that 4 TA indicator(s) are bullish while CYTK’s TA Score has 2 bullish TA indicator(s).

  • CGEN’s TA Score: 4 bullish, 3 bearish.
  • CYTK’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CGEN is a better buy in the short-term than CYTK.

Price Growth

CGEN (@Biotechnology) experienced а -2.96% price change this week, while CYTK (@Biotechnology) price change was -1.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.74%. For the same industry, the average monthly price growth was +10.27%, and the average quarterly price growth was +7.68%.

Reported Earning Dates

CGEN is expected to report earnings on Feb 20, 2025.

CYTK is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-1.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($6.06B) has a higher market cap than CGEN($147M). CGEN YTD gains are higher at: -17.172 vs. CYTK (-38.340). CGEN has higher annual earnings (EBITDA): -4.55M vs. CYTK (-459.67M). CYTK has more cash in the bank: 1.06B vs. CGEN (92M). CGEN has less debt than CYTK: CGEN (3.03M) vs CYTK (790M). CGEN has higher revenues than CYTK: CGEN (42.7M) vs CYTK (3.13M).
CGENCYTKCGEN / CYTK
Capitalization147M6.06B2%
EBITDA-4.55M-459.67M1%
Gain YTD-17.172-38.34045%
P/E RatioN/AN/A-
Revenue42.7M3.13M1,362%
Total Cash92M1.06B9%
Total Debt3.03M790M0%
FUNDAMENTALS RATINGS
CGEN vs CYTK: Fundamental Ratings
CGEN
CYTK
OUTLOOK RATING
1..100
5662
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
10045
SMR RATING
1..100
93100
PRICE GROWTH RATING
1..100
4857
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CGEN's Valuation (37) in the Biotechnology industry is somewhat better than the same rating for CYTK (100). This means that CGEN’s stock grew somewhat faster than CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (45) in the Biotechnology industry is somewhat better than the same rating for CGEN (100). This means that CYTK’s stock grew somewhat faster than CGEN’s over the last 12 months.

CGEN's SMR Rating (93) in the Biotechnology industry is in the same range as CYTK (100). This means that CGEN’s stock grew similarly to CYTK’s over the last 12 months.

CGEN's Price Growth Rating (48) in the Biotechnology industry is in the same range as CYTK (57). This means that CGEN’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for CGEN (100). This means that CYTK’s stock grew significantly faster than CGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGENCYTK
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 6 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
View a ticker or compare two or three
Ad is loading...
CGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDSCX38.750.16
+0.41%
Fidelity Stock Selector Small Cap
HTMIX10.86N/A
+0.03%
Heitman US Real Estate Secs Instl
GUBGX15.61N/A
N/A
Victory RS International A
GIIZX12.19N/A
N/A
GuideStone Funds Intl Eq Idx Investor
FTZFX50.67-0.13
-0.26%
FullerThaler Behvrll Uncnstd Eq R6

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with KRON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then KRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
-0.66%
KRON - CYTK
43%
Loosely correlated
-4.04%
IOVA - CYTK
42%
Loosely correlated
+2.41%
DARE - CYTK
42%
Loosely correlated
-5.53%
CKPT - CYTK
41%
Loosely correlated
-0.71%
DSGN - CYTK
40%
Loosely correlated
+2.31%
More